Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Capital Expenditures (2022 - 2023)

Historic Capital Expenditures for Abvc Biopharma (ABVC) over the last 4 years, with Q3 2023 value amounting to -$419374.0.

  • Abvc Biopharma's Capital Expenditures fell 972529.26% to -$419374.0 in Q3 2023 from the same period last year, while for Dec 2023 it was -$414928.0, marking a year-over-year decrease of 44666.31%. This contributed to the annual value of $21201.0 for FY2023, which is 8228.7% down from last year.
  • As of Q3 2023, Abvc Biopharma's Capital Expenditures stood at -$419374.0, which was down 972529.26% from $89.0 recorded in Q4 2022.
  • Over the past 5 years, Abvc Biopharma's Capital Expenditures peaked at $93220.0 during Q1 2022, and registered a low of -$419374.0 during Q3 2023.